NUMI.F Stock Overview
Provides psychedelic-assisted psychotherapy products and services in Canada and the United States.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Numinus Wellness Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.032 |
52 Week High | CA$0.20 |
52 Week Low | CA$0.025 |
Beta | 1.52 |
11 Month Change | -36.42% |
3 Month Change | -60.99% |
1 Year Change | -81.20% |
33 Year Change | -95.11% |
5 Year Change | n/a |
Change since IPO | -95.54% |
Recent News & Updates
Recent updates
Shareholder Returns
NUMI.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | -0.3% | -1.1% | 1.1% |
1Y | -81.2% | 17.7% | 22.5% |
Return vs Industry: NUMI.F underperformed the US Pharmaceuticals industry which returned 17.7% over the past year.
Return vs Market: NUMI.F underperformed the US Market which returned 22.5% over the past year.
Price Volatility
NUMI.F volatility | |
---|---|
NUMI.F Average Weekly Movement | 16.2% |
Pharmaceuticals Industry Average Movement | 9.7% |
Market Average Movement | 5.7% |
10% most volatile stocks in US Market | 14.9% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: NUMI.F's share price has been volatile over the past 3 months.
Volatility Over Time: NUMI.F's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1964 | n/a | Payton Nyquvest | www.numinus.com |
Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies.
Numinus Wellness Inc. Fundamentals Summary
NUMI.F fundamental statistics | |
---|---|
Market cap | US$9.42m |
Earnings (TTM) | -US$19.83m |
Revenue (TTM) | US$17.00m |
0.6x
P/S Ratio-0.5x
P/E RatioIs NUMI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NUMI.F income statement (TTM) | |
---|---|
Revenue | CA$23.14m |
Cost of Revenue | CA$15.44m |
Gross Profit | CA$7.70m |
Other Expenses | CA$34.69m |
Earnings | -CA$26.99m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.084 |
Gross Margin | 33.28% |
Net Profit Margin | -116.66% |
Debt/Equity Ratio | 2.1% |
How did NUMI.F perform over the long term?
See historical performance and comparison